Current status on the clinical usefulness of apheresis in patients with inflammatory bowel disease

Annals of Gastroenterology

Volumn 16, Issue 2, 2003, Pages 100-104

  Triantafillidis, John K ^a,b   Cherakakis, P ^a  

^a Saint Panteleimon General State Hospital   (Greece)

^b NONE   (Greece)

Author keywords

Apheresis; Crohn's disease; Inflammatory bowel disease; Leucocytapheresis; Ulcerative colitis

Indexed keywords

DIPEPTIDYL PEPTIDASE IV; LEUKOCYTE ENZYME; STEROID;

ABDOMINAL DISCOMFORT; ALLERGIC REACTION; APHERESIS; BIOFILTER; CENTRIFUGATION; CHILL; CLINICAL EFFECTIVENESS; CROHN DISEASE; DIZZINESS; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; ENZYME ACTIVITY; EXTRACORPOREAL CIRCULATION; FEVER; HEART PALPITATION; HUMAN; IMMUNOMODULATION; IMMUNOPATHOLOGY; LIP DISEASE; LYMPHOCYTE; NAUSEA; NOSE OBSTRUCTION; PATHOPHYSIOLOGY; PATIENT SAFETY; RELAPSE; REMISSION; REPERFUSION INJURY; REVIEW; SOMATOSENSORY DISORDER; TONGUE DISEASE; TREATMENT DURATION; TREATMENT RESPONSE; ULCERATIVE COLITIS; VOMITING;

EID: 45849109970     PISSN: 11087471     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Bicks RO, Groshart KD. The current status of T-lymphocyte apheresis (TLA) treatment of Crohn's disease. J Clin Gastroenterol 1989; 11:136-138.
2. Kondo K, Shinoda T, Yoshimoto H, Takazoe M. Hamada T. Effective maintenance leucocytapheresis for patients with sreroid dependent or resistant ulcerative colitis. Ther Apher 2001; 5:462-465.
3. Sawada Y, Ohnishi & Kosaka T, et al. Leukocytapheresis with leukocyte removal filter as new therapy for ulcerative colitis. Ther Apher 1997; 1:207-211.
4. Endo Y, Tsuzuki H, Fujino M, Tabata T, Oka H, Shimizu T, Hanasawa & Tani T. Off-line leukapheresis using leucofiltration for active ulcerative colitis: a case report. Ther Apher 2001; 5:480-483.
5. Shimoyama T, Sawada & Hiwatashi N, et al. Safety and efficacy of granulocyte and monocyte adsorption apheresis in patients with active ulcerative colitis: a multicenter study. J Clin Apheresis 2001; 16:1-9.
6. Sawada K, Shimoyama, T. Therapeutic cytapheresis for inflammatory bowel disease. Ther Apher 1999; 2:90-92.
7. Amano K, Amano K. Filter leukapheresis for patients with ulcerative colitis: clinical results and the possible mechanisms. Ther Apher 1998; 2:97-100.
8. Sasaki M, Tsujikawa T, Fujiyama Y, Bamba T. Leukocytapheresis therapy for severe ulcerative colitis. Ther Apher 1998; 2:101-104.
9. Ayabe T, Ashida T, Kohgo Y. Centrifugal leukocyte apheresis for ulcerative colitis. Ther Apher 1998; 2:125-128.
10. Kashiwagi N, Sugimura K, Koiwai H, Yamamoto H, Yoshikawa T, Saniabadi AR, Adachi M, Shimoyama T. Immunomodulatory effects of granulocyte and monocyte adsorption apheresis as a treatment for patients with ulcerative colitis. Dig Dis Sci 2002; 47:1334-1341.
11. Porcu P, Farag S, Marcucci G, Cataland SR, Kennedy MS, Bissell M. Leukocytoreduction for acute leukemia. Ther Apher 2002; 6:15-23.
12. Yokoyama H, Shimizu M, Wada T, et al. The beneficial effects of lymphocytapheresis for treatment of nephrotic syndrome. Ther Apher 2002; 6:167-173.
13. Kawamura A, Saitoh N, Yonekawa M, Horie T, Ohizumi H, Tamaki T, Kukita Y, Meguro J. New technique of leukocytapheresis by the use on nonwoven polyester fiber filter for inflammatory bowel disease. Ther Apher 1999; 3:334-337.
14. Yamaji Y, Tsuda H, Hashimoto H. Current topics on cytapheresis technologies. Ther Apher 2001; 5:287-292.
15. Tani T, Hanasawa K, Endo Y, Abe, H, Numa K, Kodama M. Theoretical background of effect mechanism by extracorporeal immunomodulation. Ther Apher 1997; 1:219-223.
16. Noguchi N, Hiwatashi N, Hayakawa T, Toyota T. Leukocyte removal filter-passed lymphocytes produce large amounts of interleukin-4 in immunotherapy for inflammatory bowel disease: role of bystander suppression. Ther Apher 1998; 2:109-114.
17. Ortolano GA, Capetandes A, Wenz B. A review of leukofiltration therapy for decreasing the morbidity associated with cardiopulmonary and acute inflammatory bowel disease. Ther Apher 2002; 6:119-129.
18. Sugimura K, Suzuki K, Hasegawa K, et al. Influence to active oxygen productivity of granulocyte by activated platelet of ulcerative colitis patients. In: Annual Report of the Research Committee of Inflammatory Bowel Disease. Tokyo: Ministry of Health and Welfare of Japan, 1999:93-97.
19. Yamasaki S, Ueki Y, Nakamura H, et al. Effect of filtration leukocytapheresis therapy: modulation of white blood cell enzyme activities in patients with rheumatoid arthritis. Artif Organs 2002; 26:378-384.
20. Sawada K, Ohnishi K, Kosaka T, et al. Leukocytapheresis therapy with leukocyte removal filter for inflammatory bowel disease. J Gastroenterol 1995; 30(Suppl 8):124-127.
21. Ayabe T, Ashida. T, Taniguchi M, et al. A pilot study of centrifugal leukocyte apheresis for corticosteroid-resistant active ulcerative colitis. Intern Med 1997; 36:322-326.
22. Lerebours E, Bussel A, Modigliani R, Bastit D, Florent C, Rabian C, Rene E, Soule JC. Treatment of Crohn's disease by lymphocyte apheresis: a randomized controlled trial. Gastroenterology 1994; 107:357-361.
23. Sawada K, Ohnishi K, Fukui S, et al. Leukocytapheresis therapy, performed with leukocyte removal filter, for inflammatory bowel disease. J Gastroenterol 1995; 30:322-329.
24. Kosaka T, Sawada K, Ohnishi K, et al. Effect of leukocytapheresis therapy using a leukocyte removal filter in Crohn's disease. Intern Med 1999; 38:102-111.
25. Titlestad IL, Ebbesen LS, Ainsworth AP, Lillevang ST, Qvist N, Georgsen J. Leykocyte-depleti n of blood components does not significantly reduce the risk of infectious complications. Results of a double-blinded, randomized study. Int J Colorectal Dis 2001; 16:147-153.
26. Fukunaga Y, Sawada K, Fukuda Y, et al. A case report: first case of filtration leukocytapheresis for a patient of aortitis syndrome associated with ulcerative colitis. Ther Apher 2002; 6:93-98.
27. Yajima T, Takaishi H, Kanai T, Iwaó, Watanabe M, Ishii H, Hibi T. Predictive factors of response to leukocytapheresis therapy for ulcerative colitis. The Apher 1998; 2:115-119.
28. Nagase K, Sawada K, Osnishi K, Egashira A, Ohkusu K, Shimoyama T. Complications of leukocytapheresis. Ther Apher 1998; 2:120-124.
29. Kawamura A, Osanai M, Katori M, Yonekawa M, Saitoh M. Basic clinical study of an easy and effective leukocytapheresis by the use of nonwoven polyester filter. Ther Apher 1998; 2:292-296.